Mark Lawler – ECCO 2019 European Cancer Summit
touchONCOLOGY met Professor Mark Lawler (Chair, Translational Cancer Genomics Centre for Cancer Research and Cell Biology (CCRCB), Queen’s University Belfast) at the ECCO 2019 European Cancer Summit in Brussels to discuss the EU Cancer Mission and the work of the Lancet Oncology Cancer Groundshot.
Questions
1. What do the big-data, patient-centered (high-cost) research initiatives such as the ‘Cancer Moonshot’ programme of the US government hope to achieve, and what is their likelihood of transforming cancer care? (0:08)
2. Do these large-scale initiatives represent the best strategic approach to cancer? What are they not addressing? (1:05)
3. What is the recently proposed parallel Lancet Oncology Cancer ‘Groundshot’ initiative and how would it differ from, or complement, the US ‘Moonshot’ efforts? (1:31)
4. How will this initiative help to improve cancer care in Europe? (2:59)
5. Will the Groundshot help align other European activities, such as the EU Cancer Mission? (3:40)
Mark Lawler has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European CanCer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
